Yellow fever vaccine - VaxThera
Latest Information Update: 19 Apr 2024
At a glance
- Originator VaxThera
- Class RNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Yellow fever
Most Recent Events
- 08 Apr 2024 Early research in Yellow fever (Prevention) in USA (Parenteral) (VaxThera pipeline, April 2024)